Barry Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Barry Investment Advisors's BMY Position: Q2 2025 in Review
Barry Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 9,062 shares — an estimated $553K sold.
Barry Investment Advisors first reported a position in BMY in Q4 2020 and held it in 18 quarters. The position peaked at $1.01M in Q2 2022. 2,292 funds tracked by Wall St. Rank hold BMY as of Q2 2025.
- Barry Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
- Barry Investment Advisors sold 9,062 Bristol-Myers Squibb shares in Q2 2025, an estimated $553K.
- Barry Investment Advisors first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 18 quarters.
- Barry Investment Advisors's Bristol-Myers Squibb position peaked at $1.01M in Q2 2022.
- 2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.
Based on Barry Investment Advisors's 13F filing for Q2 2025, filed 17 Jul 2025.